Close

Johnson & Johnson (JNJ) to Acquire Alios BioPharma in $1.75B Cash Deal

September 30, 2014 8:31 AM EDT Send to a Friend
Johnson & Johnson (NYSE: JNJ) announced a definitive agreement to acquire Alios BioPharma, Inc., a privately held clinical stage biopharmaceutical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login